The performance of Morgan Stanley’s MS trading business (constituting a significant portion of its top line) is expected to ...

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to $113 from $87 on HIV prevention drug Lenacapavir (PrEP) and next-gen HIV ...

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

Morgan Stanley (NYSE:MS – Get Free Report) is set to issue its quarterly earnings data before the market opens on Thursday, ...

Morgan Stanley (MS) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...

Morgan Stanley (MS) stock saw a decline, ending the day at $126.88 which represents a decrease of $-1.76 or -1.37% from the prior close of $128.64. The stock opened at $129.65 and touched a low of ...

Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley MS. And retail traders should know. We ...

Morgan Stanley closed $8.38 short of its 52-week high ($136.24), which the company achieved on November 25th.

Shares of Morgan Stanley MS shed 1.37% to $126.88 Tuesday, on what proved to be an all-around dismal trading session for the ...

In a report released today, Jason Goldberg from Barclays maintained a Buy rating on Morgan Stanley (MS – Research Report), with a price target ...

BofA raised the firm’s price target on Morgan Stanley (MS) to $146 from $140 and keeps a Buy rating on the shares. Strong Q3 results ...